Fenofibrate and
gemfibrozil may modestly increase
ezetimibe levels, although this is not thought to be clinically relevant. However, both
fibrates and
ezetimibe increase the secretion of cholesterol into the bile, which increases the risk of gallstone formation.
The manufacturers suggest that concurrent use should be avoided.